In our recent work, we showed that CD40 signaling activation by monoclonal antibody rewires metabolic circuits to enhance the anti-tumorigenic polarization of TAMs and boost anti-tumor response (Fig. 4) [148]. The gene discussed is CD40; the disease is neoplasm.